CR20230437A - Nuevos derivados de tiazolopirimidinona - Google Patents

Nuevos derivados de tiazolopirimidinona

Info

Publication number
CR20230437A
CR20230437A CR20230437A CR20230437A CR20230437A CR 20230437 A CR20230437 A CR 20230437A CR 20230437 A CR20230437 A CR 20230437A CR 20230437 A CR20230437 A CR 20230437A CR 20230437 A CR20230437 A CR 20230437A
Authority
CR
Costa Rica
Prior art keywords
new
thiazolopyrimidinone
derivatives
sup
sub
Prior art date
Application number
CR20230437A
Other languages
English (en)
Inventor
Fionn Susannah O´Hara
Delphine Gaufreteau
Nadine Grether
Hasane Ratni
Virginie Brom
Matilde Piras
Claudio Zambaldo
Cosimo Dolente
Michael Reutlinger
Walter Vifian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CR20230437A publication Critical patent/CR20230437A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a un compuesto de fórmula (I), en el que R<sup>1</sup>-R<sup>4</sup> y A<sub>1</sub>-A<sub>3</sub> son como se definen en la descripción y en las reivindicaciones. El compuesto de fórmula (I) se puede usar como un medicamento.
CR20230437A 2021-03-17 2022-03-15 Nuevos derivados de tiazolopirimidinona CR20230437A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21163259 2021-03-17
PCT/EP2022/056586 WO2022194801A1 (en) 2021-03-17 2022-03-15 New thiazolopyrimidinone derivatives

Publications (1)

Publication Number Publication Date
CR20230437A true CR20230437A (es) 2023-10-16

Family

ID=74947249

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20230437A CR20230437A (es) 2021-03-17 2022-03-15 Nuevos derivados de tiazolopirimidinona

Country Status (15)

Country Link
US (1) US20240018163A1 (es)
EP (1) EP4308576A1 (es)
JP (1) JP2024514421A (es)
KR (1) KR20230157367A (es)
CN (1) CN116981674A (es)
AU (1) AU2022240935A1 (es)
BR (1) BR112023018466A2 (es)
CA (1) CA3212341A1 (es)
CL (1) CL2023002705A1 (es)
CO (1) CO2023012574A2 (es)
CR (1) CR20230437A (es)
IL (1) IL305203A (es)
MX (1) MX2023010719A (es)
TW (1) TW202302604A (es)
WO (1) WO2022194801A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023520925A (ja) * 2020-04-08 2023-05-22 リミックス セラピューティクス インコーポレイテッド スプライシングを調節するための化合物及び方法
EP4416156A1 (en) * 2021-10-13 2024-08-21 Remix Therapeutics Inc. Compounds and methods for modulating nucleic acid splicing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20142364A1 (es) 2012-02-10 2015-01-10 Hoffmann La Roche Compuestos para tratar atrofia muscular espinal
ES2761423T3 (es) 2014-05-15 2020-05-19 Hoffmann La Roche Compuestos para tratar la atrofia muscular espinal
EP3634953B1 (en) * 2017-06-05 2024-01-03 PTC Therapeutics, Inc. Compounds for treating huntington's disease
CA3067591A1 (en) * 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. Methods for treating huntington's disease
JP7075484B2 (ja) 2017-09-22 2022-05-25 エフ.ホフマン-ラ ロシュ アーゲー 7-(4,7-ジアザスピロ[2.5]オクタン-7-イル)-2-(2,8-ジメチルイミダゾ[1,2-b]ピリダジン-6-イル)ピリド[1,2-a]ピリミジン-4-オン誘導体の製造方法
US11685746B2 (en) * 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease
BR112020026534A2 (pt) * 2018-06-27 2021-03-23 Ptc Therapeutics, Inc. Compostos de heteroarila para o tratamento da doença de huntington
JP2023520925A (ja) * 2020-04-08 2023-05-22 リミックス セラピューティクス インコーポレイテッド スプライシングを調節するための化合物及び方法

Also Published As

Publication number Publication date
TW202302604A (zh) 2023-01-16
US20240018163A1 (en) 2024-01-18
CO2023012574A2 (es) 2023-09-29
CA3212341A1 (en) 2022-09-22
JP2024514421A (ja) 2024-04-02
BR112023018466A2 (pt) 2023-10-10
CN116981674A (zh) 2023-10-31
MX2023010719A (es) 2023-09-20
WO2022194801A1 (en) 2022-09-22
EP4308576A1 (en) 2024-01-24
KR20230157367A (ko) 2023-11-16
IL305203A (en) 2023-10-01
CL2023002705A1 (es) 2024-03-15
AU2022240935A1 (en) 2023-08-24

Similar Documents

Publication Publication Date Title
MX2023010719A (es) Nuevos derivados de tiazolopirimidinona.
MX2023001379A (es) Derivados de piperidin-1-il-n-piridina-3-il-2-oxoacet amida utiles para el tratamiento de canceres deficientes en mtap y/o que acumulan mt a.
MX2023012054A (es) Inhibidor derivado heterociclico y metodo de preparacion y su aplicacion.
SG148178A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
MX2009004441A (es) Derivados de indazol utiles como inhibidores de las isoformas de higado.
MY138941A (en) Aryl-pyridine derivatives
AR047076A1 (es) Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas
MX2009003939A (es) Derivados de imidazolona e imidazolidinona como inhibidores de la 11-beta-hidroxiesteroide deshidrogenasa de tipo 1 para diabetes.
MX2009010567A (es) Derivados de imidazolidinona.
MX2010003224A (es) Derivados de biaril sulfonamida.
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
PL401636A1 (pl) Związek benzoimidazolowy, jego zastosowanie oraz zawierająca go kompozycja farmaceutyczna
MX2007009777A (es) Derivados de triazol.
TW200616940A (en) Novel hexafluoroisopropanol substituted ether derivatives
CR20200643A (es) Nuev0s compuestos de piridina y pirazina com0 inhibidores del receptor connabinoide 2
MX2022006711A (es) Nuevos inhibidores de braf como rompedores de la paradoja.
MX2010002341A (es) Derivados de bencimidazol usados como agonistas del receptor x de farnesoide.
MX2008016426A (es) Derivados de alquilpiridazina como inhibidores de 11 beta hidroxiesteroide deshidrogenasa tipo 1(11b-hsd 1).
MY145464A (en) Pyrazolone derivatives as 11-beta hsd1 inhibitors
MX2020010181A (es) Compuestos de piperidina como inhibidores covalentes de menina.
PH12018502012A1 (en) Griseofulvin compound
MX2022001789A (es) Derivados de 2-hidroxicicloalcan-1-carbamoilo.
MX2010005164A (es) Derivados de bencimidazol y su uso como agonistas del receptor x de farnesoide.
GB0314967D0 (en) Piperazine derivatives
TN2021000025A1 (en) Novel heterocyclic amine derivative and pharmaceutical composition comprising same